Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Journal of Gastroenterology|October 19, 2018
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failuresMitsutaka Osawa, Michio Imamura, Yuji Teraoka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 9, 2020
Impact of viral eradication by direct-acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus-related compensated cirrhosis patientsYuko Nagaoki, Michio Imamura, Yuji Teraoka, et al.Clinical Journal of Gastroenterology|August 30, 2019
Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapyKazuki Ohya, Michio Imamura, Mitsutaka Osawa, et al.Clinical Journal of Gastroenterology|February 2, 2019
Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shuntMaiko Namba, Tomokazu Kawaoka, Hiroshi Aikata, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 9, 2017
Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus-related cirrhosisYuko Nagaoki, Hiroshi Aikata, Kana Daijyo, et al.Plos One|April 4, 2018
Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoringFumi Honda, Akira Hiramatsu, Hideyuki Hyogo, et al.Clinical Journal of Gastroenterology|November 30, 2019
Isolated cardiac metastases of hepatocellular carcinoma after resection: a case reportYosuke Tamura, Tomokazu Kawaoka, Hiroshi Aikata, et al.Journal of Medical Virology|September 8, 2016
Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunctionYuki Nakamura, Michio Imamura, Yoshiiku Kawakami, et al.Journal of Medical Virology|November 2, 2018
The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapyYuko Nagaoki, Michio Imamura, Yuno Nishida, et al.Journal of Computer Assisted Tomography|March 12, 2016
Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular CarcinomaTomoki Kobayashi, Hiroshi Aikata, Fumi Honda, et al.Pageof 8